2003
DOI: 10.1097/01.asn.0000099374.58607.c9
|View full text |Cite
|
Sign up to set email alerts
|

Increased Renal Vascular Endothelial Growth Factor and Angiopoietins by Angiotensin II Infusion Is Mediated by Both AT1 and AT2 Receptors

Abstract: Abstract.A link between angiotensin II and cell proliferation has previously been reported. However, there remains controversy as to the role of the individual angiotensin II receptor subtypes in mediating these effects and their link to angiogenic cytokines and their receptors. Male Sprague-Dawley rats were infused with either angiotensin II or vehicle for 14 d at a dose of 58.3 ng/min. Angiotensin II-infused rats received no treatment, an AT 1 receptor antagonist valsartan (30 mg/kg per d), or an AT 2 recept… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
58
1
2

Year Published

2004
2004
2020
2020

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 79 publications
(65 citation statements)
references
References 45 publications
4
58
1
2
Order By: Relevance
“…The similarity of the beneficial effect of ACE inhibitors and AT 1 receptor antagonists in experimental models and clinical studies would further support the notion that AT 2 receptor stimulation does not contribute to the pathogenesis of renal disease. Other recent studies have challenged the view of AT 2 as a "protective" receptor (40) and provided evidence that the growth stimulatory and proinflammatory effects of Ang II also may be transduced by AT 2 , which induces glomerular cell proliferation and monocyte/macrophage infiltration, albeit to a lower extent than AT 1 receptor (41,42). This observation together with the evidence of AT 2 upregulation in protein-overload proteinuria (43) would offer the rationale for studies with specific AT 2 antagonists.…”
Section: Discussionmentioning
confidence: 99%
“…The similarity of the beneficial effect of ACE inhibitors and AT 1 receptor antagonists in experimental models and clinical studies would further support the notion that AT 2 receptor stimulation does not contribute to the pathogenesis of renal disease. Other recent studies have challenged the view of AT 2 as a "protective" receptor (40) and provided evidence that the growth stimulatory and proinflammatory effects of Ang II also may be transduced by AT 2 , which induces glomerular cell proliferation and monocyte/macrophage infiltration, albeit to a lower extent than AT 1 receptor (41,42). This observation together with the evidence of AT 2 upregulation in protein-overload proteinuria (43) would offer the rationale for studies with specific AT 2 antagonists.…”
Section: Discussionmentioning
confidence: 99%
“…Ang II-induced hypertrophy of cultured murine proximal tubular cells was shown to be mediated by endogenous TGF-␤ (368). Ang II also stimulates VEGF expression and PTC modulation, both via transcriptional and translational mechanisms (65,272). The translational increase in VEGF expression is brief (detected at 5 min and lasts 45 min) and is mediated by activation of PI3-kinase and its downstream target Akt.…”
Section: B Ros and The Glomerular Basement Membrane (Gbm)mentioning
confidence: 99%
“…In cultured podocytes, VEGF expression can be stimulated by high glucose concentrations (91), by TGF-␤1 (91,92), and by ANG II acting via AT 1 and AT 2 receptors (93,94). The gene expression of VEGF is also stimulated by a transcription factor called hypoxia-inducible factor-1 (95).…”
Section: Role Of Vascular Endothelial Growth Factormentioning
confidence: 99%